Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0000950170-24-066177

Chief Operating Officer sold 7,910 shares at $74.31 ($587,813)

  • Chief Operating Officer acquired 13,693 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Jacobson Mark L. Chief Operating Officer 2024-05-29 Option exercise +13,693 $1.30 $17,801 13,693 D
Jacobson Mark L. Chief Operating Officer 2024-05-29 Sale −7,910 $74.31 $587,813 5,783 D
Derivatives
Jacobson Mark L. Chief Operating Officer 2024-05-29 Option exercise · Stock Option (Right to Buy) −13,693 0 D
Open-market sales · 7,910 sh · avg $74.31 · $587,813
Loading xslF345X05/ownership.xml…